AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2021
Feb 17, 2021
30016_dirs_2021-02-17_51daad0d-7553-47f7-992e-dcd5b13195a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-14
Reporting Person: MAZELSKY JONATHAN JAY (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-14 | Common Stock | M | 737 | — | Acquired | 42164 | Direct |
| 2021-02-14 | Common Stock | M | 459 | — | Acquired | 42623 | Direct |
| 2021-02-14 | Common Stock | M | 505 | — | Acquired | 43128 | Direct |
| 2021-02-14 | Common Stock | M | 435 | — | Acquired | 43563 | Direct |
| 2021-02-14 | Common Stock | M | 974 | — | Acquired | 44537 | Direct |
| 2021-02-14 | Common Stock | F | 1447 | $544.08 | Disposed | 43090 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-14 | Non-Qualified Stock Option (right-to-buy) | $544.08 | A | 17674 | Acquired | 2031-02-13 | Common Stock (17674) | Direct |
| 2021-02-14 | Premium Non-Qualified Stock Option (right-to-buy) | $598.4880 | A | 9717 | Acquired | 2021-02-13 | Common Stock (9717) | Direct |
| 2021-02-14 | Premium Incentive Stock Option (right-to-buy) | $598.4880 | A | 183 | Acquired | 2031-02-13 | Common Stock (183) | Direct |
| 2021-02-14 | Restricted Stock Unit | $ | A | 2757 | Acquired | Common Stock (2757) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 737 | Disposed | Common Stock (737) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 459 | Disposed | Common Stock (459) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 505 | Disposed | Common Stock (505) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 435 | Disposed | Common Stock (435) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 974 | Disposed | Common Stock (974) | Direct |
Footnotes
F1: Includes 14 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2020.
F2: Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.
F3: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.
F4: Grant of option at a 110% premium to the closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021 to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.
F5: Grant of option at a 110% premium to the closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021 to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.
F6: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2017.
F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.
F9: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.
F10: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
F11: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
F12: Not applicable.